Alpine Immune Sciences (ALPN)
(Delayed Data from NSDQ)
$64.55 USD
+0.06 (0.09%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $64.55 0.00 (0.00%) 6:08 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.43 |
EPS Last Quarter | 0.15 |
Last EPS Surprise | 146.88% |
ABR | 2.75 |
Earnings ESP
|
-4.65% |
---|---|
Current Year | -1.74 |
Next Year | -1.90 |
EPS (TTM) | -0.64 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 5.50M | 5.50M | 22.33M | 40.00M |
# of Estimates | 3 | 3 | 3 | 2 |
High Estimate | 10.00M | 10.00M | 40.00M | 40.00M |
Low Estimate | 3.00M | 3.00M | 12.00M | 40.00M |
Year ago Sales | 9.39M | 8.59M | 58.88M | 22.33M |
Year over Year Growth Est. | -41.43% | -35.97% | -62.07% | 79.11% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.43 | -0.42 | -1.74 | -1.90 |
# of Estimates | 6 | 5 | 6 | 6 |
Most Recent Consensus | -0.45 | -0.45 | -1.84 | -1.95 |
High Estimate | -0.29 | -0.30 | -1.23 | -1.16 |
Low Estimate | -0.51 | -0.50 | -1.95 | -2.45 |
Year ago EPS | -0.28 | -0.27 | -0.64 | -1.74 |
Year over Year Growth Est. | -53.57% | -55.56% | -171.88% | -9.57% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 3 | 3 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.43 | -0.42 | -1.74 | -1.90 |
7 Days Ago | -0.43 | -0.42 | -1.74 | -1.90 |
30 Days Ago | -0.44 | -0.43 | -1.76 | -1.92 |
60 Days Ago | -0.29 | -0.31 | -1.46 | -1.72 |
90 Days Ago | -0.23 | -0.24 | -1.38 | -1.75 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.45 | -0.45 | -1.81 | -2.15 |
Zacks Consensus Estimate | -0.43 | -0.42 | -1.74 | -1.90 |
Earnings ESP | -4.65% | -6.13% | -3.93% | -12.96% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.15 | -0.24 | -0.27 | -0.28 | NA |
Estimate | -0.32 | -0.35 | -0.38 | -0.37 | NA |
Difference | 0.47 | 0.11 | 0.11 | 0.09 | 0.20 |
Surprise | 146.88% | 31.43% | 28.95% | 24.32% | 57.90% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more